4.4 Article

Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro

期刊

PATHOBIOLOGY
卷 69, 期 3, 页码 120-126

出版社

KARGER
DOI: 10.1159/000048766

关键词

autophagy; breast cancer; medroxyprogesterone; tamoxifen; epirubicin

向作者/读者索取更多资源

Objective: Autophagy is a form Of physiological programmed cell death Which is, observable after hormonal withdrawal. In this study, the FM3A murine breast tumor cell line was treated with epirubicin alone and with medroxyprogesterone, acetate: (MPA) or tamoxifen, to determine if structural and kinetic signs, of autophagy may also Occur in an enhanced manner during epirubicin sensitization via hormonal, agents. Methods: One-week soft agar colony growth, 96-hour values of plating and pulse thymidine, labeling and electron microscopical examinations were performed following treatment with MPA and tamoxifen alone: or with epirubicin. Results. Tamoxifen. induced signs of autophagy, which was enhanced. when it was combined with M PA. Epirubicin also induced autophagy of secretory granules, which coalesced to form an intracytoplasmic lumen. Combining MPA with epirubicin enhanced the, formation of apoptotic blebs and chromatin fragmentation. When epirubicin was combined with tamoxifen, peculiar nuclear structures were formed. Conclusions: Hormonal agents may modulate anthracycline activity towards specific patterns in eliciting cell death, via autophagy and/or as yet unknown nucleolus-specific interactions. Copyright (C) 2002 S. Karger AG, Basel.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据